HALT & REVERSE: Hsf1 activators lower cardiomyocyt damage; towards a novel approach to REVERSE atrial fibrillation

E.A.H. Lanters, D.M.S. van Marion, C. Kik, H. Steen, A.J.J.C. Bogers, M.A. Allessie, B.J.J.M. Brundel, N.M.S. de Groot

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)347
JournalJournal of Translational Medicine
Volume13
DOIs
Publication statusPublished - 2015

Cite this

Lanters, E. A. H., van Marion, D. M. S., Kik, C., Steen, H., Bogers, A. J. J. C., Allessie, M. A., ... de Groot, N. M. S. (2015). HALT & REVERSE: Hsf1 activators lower cardiomyocyt damage; towards a novel approach to REVERSE atrial fibrillation. Journal of Translational Medicine, 13, 347. https://doi.org/10.1186/s12967-015-0714-7